Top Biotechnology companies in Cayman Islands by Revenue Per Share

This ranking features the top 3 Biotechnology companies in Cayman Islands ranked by Revenue Per Share, averaging a Revenue Per Share of USD 0.94, for January 15, 2025.

Cayman Islands

Biotechnology

#	Name	Revenue Per Share	Reported Date	Stock Price	Change	Country
1	All Cosmos Bio-Tech Holding Corporation 1 4148.TW	USD 1.44	Dec. 31, 2023	USD 1.47	0.53%	Cayman Islands
2	Theravance Biopharma, Inc. 2 TBPH	USD 1.04	Dec. 31, 2023	USD 8.53	-0.47%	Cayman Islands
3	Adlai Nortye Ltd. American Depositary Shares 3 ANL	USD 0.35	Dec. 31, 2023	USD 2.01	1.52%	Cayman Islands

Frequently Asked Questions

Which Biotechnology company in Cayman Islands has the highest Revenue Per Share ?

The Biotechnology company in Cayman Islands with the highest Revenue Per Share is All Cosmos Bio-Tech Holding Corporation (Taiwan Stock Exchange: 4148.TW) at USD 1.44.
Which Biotechnology company in Cayman Islands has the lowest Revenue Per Share ?

The Biotechnology company in Cayman Islands with the lowest Revenue Per Share is Adlai Nortye Ltd. American Depositary Shares (NasdaqGM: ANL) at USD 0.35.

What are the top 10 Biotechnology companies in Cayman Islands by Revenue Per Share ?

The top 10 Biotechnology companies in Cayman Islands by Revenue Per Share are All Cosmos Bio-Tech Holding Corporation, Theravance Biopharma, Inc. and Adlai Nortye Ltd. American Depositary Shares.
What are the bottom 10 Biotechnology companies in Cayman Islands by Revenue Per Share ?

The bottom 10 Biotechnology companies in Cayman Islands by Revenue Per Share are Adlai Nortye Ltd. American Depositary Shares, Theravance Biopharma, Inc. and All Cosmos Bio-Tech Holding Corporation.